Glibenclamide
Glibenclamide is a pharmaceutical drug with 26 clinical trials. Currently 1 active trials ongoing. Historical success rate of 89.5%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
5
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.5%
17 of 19 finished
10.5%
2 ended early
1
trials recruiting
26
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
Clinical Trials (26)
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism
Evaluate the Use of Glibenclamide on Acute aSAH
To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI
The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers
The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage
Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes
Low dosE GlibENclamide in Diabetes Part A
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS
Risk of Hypoglycemia in Type 2 Diabetes
Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study
Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
Cardioprotective Effects of GLP-1 and Their Mechanisms
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 26